首页> 外国专利> Production of Immunotoxin D2C7 - (scdsFv) -PE38KDEL

Production of Immunotoxin D2C7 - (scdsFv) -PE38KDEL

机译:免疫毒素D2C7-(scdsFv)-PE38KDEL的生产

摘要

D2C7-(scdsFv)-PE38KDEL (D2C7-IT) is a recombinant Pseudomonas exotoxin A-based immunotoxin (IT), targeting both wild-type epidermal growth factor receptor (EGFRwt) and mutant EGFR variant III (EGFRvIII) proteins overexpressed in glioblastomas. A good laboratory practice (GLP) manufacturing process was developed to produce sufficient material for a Phase I/II clinical trial. D2C7-IT was expressed under the control of the T7 promoter in Escherichia coli BLR (λ DE3). D2C7-IT was produced by a 10 L batch fermentation process and was then purified from inclusion bodies using anion exchange, size exclusion, and an endotoxin removal process that achieved a yield of over 300 mg of purified protein.
机译:D2C7-(scdsFv)-PE38KDEL(D2C7-IT)是一种基于

假单胞菌外毒素A的重组免疫毒素(IT),靶向野生型表皮生长因子受体(EGFRwt)和突变型EGFR变体III( EGFRvIII)蛋白在胶质母细胞瘤中过表达。开发了良好的实验室规范(GLP)制造工艺,以生产足够的材料用于I / II期临床试验。 D2C7-IT在大肠杆菌(λDE3)中在T7启动子的控制下表达。 D2C7-IT是通过10 L分批发酵过程生产的,然后使用阴离子交换,尺寸排阻和内毒素去除过程从包涵体中纯化,从而获得了300 mg以上的纯化蛋白。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号